Equipped with the latest medical and technological innovations, we have invented a state-of-the-art portable SD1 auto dry biochemistry analyzer which provides a better, faster and more accurate diagnosis for blood analysis.
ADVANTAGES
· Low Sample Consumption Sample Volume needed is 1/10-1/20 of conventional chemistry analyzer.
· Easy to Use No professional skill required.
· Maintenance Free Robust analyzer, no consumables needed, such as tubes, pumps and valves.
· Accurate Result Using the photoelectric colorimetric principle, the SD1 analyzer has many advantages versus conventional dry biochemistry analyzer using the light reflection method.Dilution of test sample is guaranteed without random errors or cross contamination.
EASY 3-STEP OPERATION
All steps are automated from centrifugation ,dilution,quality control to test result printing.
Medomics Reagent Disc Introduction Born from space technology research,Medomics reagent disc is a fully self-contained single-use chemistry reagent disc designed to satisfy a variety of conditions.Just 3-4 drops (100μl ) of whole blood are required to offer accurate results.The test kit consists of lyophilized reagent beads,diluent and QR code, The reagenf disc has a shelf life of 12 months(2-8ºC storage). The diluent is contained in the disc. The QR code includes the basic information of the disc.
Intelligent Quality Control The reagent disc contains a complicated internal quality control system IQC which continuously monitors the disc function to ensure reaction stability and optimal disc performance. IQC is the engine that drives the SD1 accurately and precisely.
Correlation In countless central-lab correlation studies, the accuracy, precision and reproducibility of the SD1 chemistry analyzer has been proven and approved by the most respected hospitals and commercial around the world.
About Medomics
Jiangsu Medomics Medical Technology Co., Ltd., is located at Biotech and Pharmaceutical Valley of the National Jiangbei New Area, Nanjing, Jiangsu Province. It is an international high-tech enterprise driven by innovation in the area of medical devices R&D, production and sales. Medomics focuses on diagnosis of microorganisms, tumors and some rare diseases, mainly engaged in the research and development, production and sales of in vitro diagnostic reagents and automatic instruments.
Medomics owns two R&D centers in China and the US, independent intellectual property rights of fluorescent staining technology, protein labeling technology, time-resolved immunofluorescence detection technology, image processing and analysis technology and other innovative technology platforms, as well as a total of more than 10,000 square meters of GMP purification production workshop that meets the product standards of FDA, CE and CFDA. Until now, Medomics has more than 100 employees across the world and R&D personnel accounts for over 50%. Medomics also has a multidisciplinary expert team with abundant experience in the industry, including senior experts in immunology, microbiology, applied physics, polymer materials, medical imaging, optical systems, etc. The members of the technical team are led by doctors from many famous institutions, such as Osaka University, North Carolina University, University of Nebraska Lincoln, Zhejiang University, Sichuan University and other institutions.
Complaint
